CN101389599A - 改性的氨基酸 - Google Patents

改性的氨基酸 Download PDF

Info

Publication number
CN101389599A
CN101389599A CNA2006800534712A CN200680053471A CN101389599A CN 101389599 A CN101389599 A CN 101389599A CN A2006800534712 A CNA2006800534712 A CN A2006800534712A CN 200680053471 A CN200680053471 A CN 200680053471A CN 101389599 A CN101389599 A CN 101389599A
Authority
CN
China
Prior art keywords
formula
ester
group
ppm
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800534712A
Other languages
English (en)
Chinese (zh)
Inventor
乌尔里克·乔迪斯
杰伊旺特·B·波帕塞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TU Wien
Original Assignee
TU Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TU Wien filed Critical TU Wien
Publication of CN101389599A publication Critical patent/CN101389599A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
CNA2006800534712A 2006-02-27 2006-11-24 改性的氨基酸 Pending CN101389599A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06450025A EP1826199A1 (en) 2006-02-27 2006-02-27 Modified amino acids
EP06450025.9 2006-02-27

Publications (1)

Publication Number Publication Date
CN101389599A true CN101389599A (zh) 2009-03-18

Family

ID=36645811

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800534712A Pending CN101389599A (zh) 2006-02-27 2006-11-24 改性的氨基酸

Country Status (5)

Country Link
US (1) US20090105091A1 (cg-RX-API-DMAC7.html)
EP (2) EP1826199A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009528282A (cg-RX-API-DMAC7.html)
CN (1) CN101389599A (cg-RX-API-DMAC7.html)
WO (1) WO2007095980A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106928454A (zh) * 2015-12-30 2017-07-07 北京大学 聚氨基酸化合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240279285A1 (en) * 2021-06-17 2024-08-22 The Regents Of The University Of California Rippled Antiparallel Cross-Beta Dimers and Related Materials, Compositions and Methods
WO2023122587A2 (en) * 2021-12-20 2023-06-29 The Board Of Regents Of The University Of Texas System Tripeptide linkers and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1150391B (de) 1962-04-19 1963-06-20 Bayer Ag Verfahren zur Herstellung von N-Alkoxycarbonyl-carbonylaminoaryl-o-carbonsaeure-acylhydraziden
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US4863947A (en) * 1985-01-11 1989-09-05 Rohm And Haas N-aryl-3-aryl-4,5-dihydro-1H-pyrazole-1-carboxamides and methods of their production
EP0573608A1 (en) 1991-02-07 1993-12-15 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
KR950702839A (ko) 1992-08-27 1995-08-23 스티븐 딕 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
US5446128A (en) * 1993-06-18 1995-08-29 The Board Of Trustees Of The University Of Illinois Alpha-helix mimetics and methods relating thereto
JP2000141893A (ja) * 1998-11-06 2000-05-23 Mitsubishi Paper Mills Ltd 可逆性感熱記録材料
EP1210360A4 (en) 1999-08-23 2005-03-02 Univ California COMPOUNDS THAT OBTAIN BETA STRANDS OF PEPTIDES
US7919623B2 (en) * 2004-02-04 2011-04-05 Shionogi & Co., Ltd. Naphthyridine derivatives having inhibitory activity against HIV integrase
WO2005103012A1 (ja) 2004-04-21 2005-11-03 Ono Pharmaceutical Co., Ltd. ヒドラジノ複素環ニトリル化合物およびその用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106928454A (zh) * 2015-12-30 2017-07-07 北京大学 聚氨基酸化合物

Also Published As

Publication number Publication date
EP1989180A1 (en) 2008-11-12
WO2007095980A8 (en) 2007-10-18
EP1826199A1 (en) 2007-08-29
US20090105091A1 (en) 2009-04-23
WO2007095980A1 (en) 2007-08-30
JP2009528282A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
JP6854771B2 (ja) 薬学的に適切なペプチドを調製するための方法
JP2002517508A (ja) C型肝炎ウィルスns3プロテアーゼのペプチド系抑制剤
WO2011012746A2 (es) Compuestos inhibidores de apaf-1
Vorobyeva et al. Synthesis of CF3-containing tetrapeptide surrogates via Ugi reaction/dipolar cycloaddition sequence
CN108727468B (zh) 环肽、包含其的医药或化妆品组成物及其制备方法
CN114096554A (zh) 肽及其制造方法
CN107810189B (zh) 用于制备氮芥衍生物的方法
JP2017043615A (ja) 環状ペプチドの膜透過性および/または代謝安定性を改善するシクロプロパンアミノ酸ユニット
CN1076200A (zh) 新型β-氨基酸衍生物
JP2003073396A (ja) ペプチドの製造方法
KR20220059479A (ko) 트로피네타이드의 조성물
JP2002502378A (ja) グアニジル化試薬
CN111606970A (zh) 一种1,5-二氮杂双环[5,3,0]十烷酮氨基酸衍生物及其制备方法和应用
Woo et al. The use of aryl hydrazide linkers for the solid phase synthesis of chemically modified peptides
Takahashi et al. Novel matrix metalloproteinase inhibitors: Generation of lead compounds by the in silico fragment-based approach
EP2542527A2 (en) Process for the preparation of atazanavir sulfate substantially free of diastereomers
TW201938576A (zh) 環胜肽、包含其之醫藥或化妝品組成物及其製備方法
CN101823990A (zh) 氨基酸酯基二硫代甲酸酯类化合物及其制备方法和用途
EP1826199A1 (en) Modified amino acids
CN109232712A (zh) 一种用于抗体药物偶联物的中间体的制备方法
WO2021177336A1 (ja) ペプチド及び細胞膜透過剤
HU220756B1 (hu) Tioacilező reagensként alkalmazható benzimidazolszármazékok és eljárás azok előállítására
WO2024075813A1 (ja) ジケトピペラジン化合物を用いるポリペプチド合成
JP4378745B2 (ja) 新規炭酸エステルおよびこれを用いたアミド化反応
Sureshbabu et al. Peptidyl carbamates: efficient synthesis using N-Fmoc-β-aminoalkoxy carbonyl chlorides/active Pentachlorophenyl carbonates as monomeric Building blocks

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090318